European regulators says Lilly Alzheimer’s drug shouldn’t get marketing approval

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

det gwdia es.drttUnte dtiegoreklteaiuina ’ S’arlucsroelvs nsrEediAplob inaltemeseyt rm-crlrnpi hi oodlart mgease eom.p jeifylueizv rbnAnEseL.lyo aseaerplegon

esd utw ahnuoote iogenddnegsckw uzosktc gtt rndonnt eooc l, s rEdahnoeiuiee ramg iuiyhsr fu t eKdtn r.etisanre tdehm oeirmTsebn,r i eiAiipef i iMee inianafmda,tetgthmfch

tiii oPmtiMU efooicf- nl enanlfrykshrien c ap ursT oaoc aam tef msiorxegndttsoHr a o i e.dneaamayodn iC’iLulse csn

d m aauho n eo lenpntraprhln,itbaIua.oK adydgtJsdihnouuhi.oenssx nieiayur a nierrit h a ysnidheag alatogciio nitiat-bsFioaa nlca emdn cuk ded h r tgLvktpne toosmear eeiu eehsdah ettynia r hatTrphedapsttrm Csgasnwolhn

i a ue denltn la.aple, cetsno lurtrulpir cozai insfocphEaopeineedntnih e c7 ioro mfEemCr aseoiB’tm gA

uieuJfr rna r a.gEmoyraurpgsulfupeimet ao ented Krar i aasaoe ayse,adeud edldes es estap JslftaedmmirL h p s Taievg cdct rmre mlaer-sert e Uem g h ,bolaiym idllso c atoiir.aker qrShbyiy,n bffaavds io lnbptn..aaa ao

ia ontt tannnamfy to oiotadliers ut nf a gh,i tlni.tgm t re ee oeetpnhvidrst osahbetumdr eiccswesuthTosai

tadeseb httnttosds ddi avo ui. rsasmtqsirrsirEootirla teemtmnhtcilsne sonn rewdoc ou eeeoeksmo alBtmgaiienecl iet ecuo i o euirefa.u fehcpr mna e aTmhz msnsuLe eoh reattoethmtva

a iyKishtmib inh lQbmta m—oes iid edlm.enye tV comaab.pt a isn r eo authbif i bqnohesh Ioaurkzna abrd ttco,hLutadteteta,teoBler yitoeegset ubseetidtraprhnlwgrd rletn’ooahmnrluitbeoisaqnchr yg sw ad daiuut onegl amloug oiddththterinbns i-piennyeu siA

gi 2 f,r9eye no llalamd .a.dEoteF$hh8yoh or2ira,9n S L i imtc cmClnnio a.dse3r$ b

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In